Basic Information
ID: ALA4341561
Type: Functional
Description: Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion at 20 uM supplemented with fresh medium containing compound every 3 days for 6 days and measured on day 9 by ELISA relative to control
Format: BAO_0000218
Organism: Hepatitis B virus
Target: Hepatitis B virus(ALA613497)
Document: ALA4340532
Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion at 20 uM supplemented with fresh medium containing compound every 3 days for 6 days and measured on day 9 by ELISA relative to control: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4341561
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 229.26 | -0.59 | -0.59 |
| 340.36 | 0.41 | 0.41 |
| 374.38 | 0.81 | 0.81 |
| 324.32 | -0.23 | -0.23 |
| 360.35 | 0.94 | 0.94 |
| 284.25 | -1.22 | -1.22 |
| 412.78 | 1.74 | 1.74 |
| 298.28 | -0.76 | -0.76 |
| 285.24 | -1.51 | -1.51 |